Effect of polyisobutylene on ethyl cellulose-walled microcapsules: wall structure and thickness of salicylamide and theophylline microcapsules.
Microcapsules were prepared by the ethylcellulose coacervation process which is based on the differential thermal solubility in cyclohexane. When a protective colloid, polyisobutylene, was present in adequate concentration, individually film-coated core particles formed. However, they were accompanied by small empty coacervate droplets, detectable by microscopic observation. Below the critical colloid concentration, the product had the form of aggregate, in contrast to individual film-coated microcapsules. Increase of colloid concentration yielded microcapsules of higher drug content, because coating became progressively thinner; there was a corresponding increase in the release rate of drugs from the microcapsules. Since the initial wall polymer/drug ratio and the particle size are constant, the drug content varied with the thicknesses of the wall membrane. This is shown here by removal of empty coacervate droplets by repeated decantations, enabling determination of drug content by chemical analysis. In contrast to results reported in the literature, in the presence of a protective colloid, microcapsule drug content decreased with decreasing particle size of the drug. This was caused by more complete uptake of the wall polymer on the increased surface of core material. The effect of protective colloid concentration on the apparent loss of wall polymer as empty droplets closely paralleled its effect on the size of stabilized droplet formation is a side reaction when core material is present, causing changes in wall thickness. This reaction not only affects the efficiency of the coating process but may be utilized to control wall thickness. First-order constants for drug release from salicylamide and theophylline microcapsules followed the same pattern as wall thickness and confirmed the validity of the measurements.